In cancer, the p85a subunit is frequently reduced in expression or mutated, leading the catalytic subunit p110 to associate with another regulatory subunit p85b, encoded by the gene PIK3R2, leading to high levels of PI3K lipid kinase activity [60,61,62,63]. This evidence concerns the gene PIK3CA and cancer.